A detailed history of State Street Corp transactions in Moderna, Inc. stock. As of the latest transaction made, State Street Corp holds 16,847,212 shares of MRNA stock, worth $622 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
16,847,212
Previous 15,023,936 12.14%
Holding current value
$622 Million
Previous $1.78 Billion 36.89%
% of portfolio
0.05%
Previous 0.08%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$63.64 - $125.14 $116 Million - $228 Million
1,823,276 Added 12.14%
16,847,212 $1.13 Billion
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $57.9 Million - $95.3 Million
571,901 Added 3.96%
15,023,936 $1.78 Billion
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $14.7 Million - $19.8 Million
-171,688 Reduced 1.17%
14,452,035 $1.54 Billion
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $46.7 Million - $70.2 Million
672,447 Added 4.82%
14,623,723 $1.45 Billion
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $26.6 Million - $34.9 Million
-275,951 Reduced 1.94%
13,951,276 $1.44 Billion
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $17.9 Million - $24.2 Million
150,872 Added 1.07%
14,227,227 $1.73 Billion
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $30.4 Million - $44.1 Million
-224,062 Reduced 1.57%
14,076,355 $2.16 Billion
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $24.3 Million - $43.2 Million
-205,649 Reduced 1.42%
14,300,417 $2.57 Billion
Q3 2022

Nov 15, 2022

SELL
$118.07 - $194.18 $30.8 Million - $50.6 Million
-260,514 Reduced 1.76%
14,506,066 $1.72 Billion
Q2 2022

Aug 15, 2022

SELL
$117.13 - $176.59 $9.43 Million - $14.2 Million
-80,550 Reduced 0.54%
14,766,580 $2.11 Billion
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $2.05 Million - $3.82 Million
-16,240 Reduced 0.11%
14,847,130 $2.56 Billion
Q4 2021

Feb 14, 2022

BUY
$225.82 - $368.51 $205 Million - $334 Million
905,789 Added 6.49%
14,863,370 $3.77 Billion
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $1.47 Billion - $3.21 Billion
6,632,005 Added 90.53%
13,957,581 $5.37 Billion
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $171 Million - $309 Million
1,316,702 Added 21.91%
7,325,576 $1.72 Billion
Q1 2021

May 17, 2021

SELL
$109.18 - $185.98 $1.73 Million - $2.94 Million
-15,813 Reduced 0.26%
6,008,874 $787 Million
Q4 2020

Feb 16, 2021

SELL
$65.74 - $169.86 $36.8 Million - $95 Million
-559,240 Reduced 8.49%
6,024,687 $629 Million
Q3 2020

Nov 10, 2020

BUY
$54.34 - $94.85 $30.3 Million - $52.8 Million
556,953 Added 9.24%
6,583,927 $466 Million
Q2 2020

Aug 14, 2020

BUY
$29.67 - $80.0 $15.7 Million - $42.4 Million
530,003 Added 9.64%
6,026,974 $387 Million
Q1 2020

May 11, 2020

BUY
$17.78 - $31.58 $97.7 Million - $174 Million
5,496,971 New
5,496,971 $165 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.